Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the schedule hereto:
Schedule
Product: Angiomax
Active Ingredient(s): Bivalirudin 100mg
Dosage Form: Powder for injection
NZ Sponsor: The Medicines Company
Manufacturer(s): Ben Venue Laboratories Inc, Bedford, Ohio, United States of America
Note: This consent is valid for 2 years from the date of publication of this notice.
Product: Calciferol Strong
Active Ingredient(s): Ergocalciferol 1.25mg equivalent to 50,000units
Dosage Form: Tablet
NZ Sponsor: PSM Healthcare Limited
Manufacturer(s): PSM Healthcare Limited, Wiri, Auckland
Note: This consent is valid for 2 years from the date of publication of this notice.
Dated this 2nd day of February 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).